vs
BXP, Inc.（BXP）与德康医疗（DXCM）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是BXP, Inc.的1.4倍（$1.3B vs $872.1M），德康医疗净利率更高（21.2% vs 15.3%，领先6.0%），德康医疗同比增速更快（21.6% vs 0.8%），过去两年德康医疗的营收复合增速更高（12.0% vs 1.3%）
BXP是美国头部商业地产投资信托企业，核心业务为持有、运营及开发A级高端写字楼资产，项目覆盖纽约、波士顿、旧金山等美国核心都市圈，服务企业、科技、专业服务等领域的多元租户。
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
BXP vs DXCM — 直观对比
营收规模更大
DXCM
是对方的1.4倍
$872.1M
营收增速更快
DXCM
高出20.8%
0.8%
净利率更高
DXCM
高出6.0%
15.3%
两年增速更快
DXCM
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $872.1M | $1.3B |
| 净利润 | $133.0M | $267.3M |
| 毛利率 | — | 62.9% |
| 营业利润率 | — | 25.6% |
| 净利率 | 15.3% | 21.2% |
| 营收同比 | 0.8% | 21.6% |
| 净利润同比 | 53.0% | 153.6% |
| 每股收益（稀释后） | $1.69 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXPDXCM
| Q1 26 | $872.1M | $1.3B | ||
| Q4 25 | $877.1M | $1.3B | ||
| Q3 25 | $871.5M | $1.2B | ||
| Q2 25 | $868.5M | $1.2B | ||
| Q1 25 | $865.2M | $1.0B | ||
| Q4 24 | $858.6M | $1.1B | ||
| Q3 24 | $859.2M | $994.2M | ||
| Q2 24 | $850.5M | $1.0B |
净利润BXPDXCM
| Q1 26 | $133.0M | $267.3M | ||
| Q4 25 | $248.4M | $267.3M | ||
| Q3 25 | $-121.7M | $283.8M | ||
| Q2 25 | $89.0M | $179.8M | ||
| Q1 25 | $61.2M | $105.4M | ||
| Q4 24 | $-228.9M | $151.7M | ||
| Q3 24 | $83.6M | $134.6M | ||
| Q2 24 | $79.6M | $143.5M |
毛利率BXPDXCM
| Q1 26 | — | 62.9% | ||
| Q4 25 | 58.8% | 62.9% | ||
| Q3 25 | 59.3% | 60.5% | ||
| Q2 25 | 59.2% | 59.5% | ||
| Q1 25 | 59.2% | 56.9% | ||
| Q4 24 | 59.7% | 58.9% | ||
| Q3 24 | 59.5% | 59.7% | ||
| Q2 24 | 59.8% | 62.4% |
营业利润率BXPDXCM
| Q1 26 | — | 25.6% | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | — | 18.4% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 15.7% |
净利率BXPDXCM
| Q1 26 | 15.3% | 21.2% | ||
| Q4 25 | 28.3% | 21.2% | ||
| Q3 25 | -14.0% | 23.5% | ||
| Q2 25 | 10.2% | 15.5% | ||
| Q1 25 | 7.1% | 10.2% | ||
| Q4 24 | -26.7% | 13.6% | ||
| Q3 24 | 9.7% | 13.5% | ||
| Q2 24 | 9.4% | 14.3% |
每股收益（稀释后）BXPDXCM
| Q1 26 | $1.69 | $0.67 | ||
| Q4 25 | $1.56 | $0.67 | ||
| Q3 25 | $-0.77 | $0.70 | ||
| Q2 25 | $0.56 | $0.45 | ||
| Q1 25 | $0.39 | $0.27 | ||
| Q4 24 | $-1.46 | $0.37 | ||
| Q3 24 | $0.53 | $0.34 | ||
| Q2 24 | $0.51 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | $917.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.7B | $2.7B |
| 总资产 | $25.1B | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BXPDXCM
| Q1 26 | $512.8M | $917.7M | ||
| Q4 25 | $1.5B | $917.7M | ||
| Q3 25 | $861.1M | $1.8B | ||
| Q2 25 | $447.0M | $1.2B | ||
| Q1 25 | $398.1M | $904.9M | ||
| Q4 24 | $1.3B | $606.1M | ||
| Q3 24 | $1.4B | $621.2M | ||
| Q2 24 | $685.4M | $939.2M |
股东权益BXPDXCM
| Q1 26 | $7.7B | $2.7B | ||
| Q4 25 | $5.1B | $2.7B | ||
| Q3 25 | $5.0B | $2.7B | ||
| Q2 25 | $5.3B | $2.6B | ||
| Q1 25 | $5.3B | $2.3B | ||
| Q4 24 | $5.4B | $2.1B | ||
| Q3 24 | $5.8B | $2.0B | ||
| Q2 24 | $5.8B | $2.4B |
总资产BXPDXCM
| Q1 26 | $25.1B | $6.3B | ||
| Q4 25 | $26.2B | $6.3B | ||
| Q3 25 | $26.0B | $7.5B | ||
| Q2 25 | $25.6B | $7.3B | ||
| Q1 25 | $25.4B | $6.8B | ||
| Q4 24 | $26.1B | $6.5B | ||
| Q3 24 | $26.4B | $6.4B | ||
| Q2 24 | $25.5B | $6.8B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
DXCM
暂无分部数据
